Time to reversal, days (SD) | p value | |
---|---|---|
Age | 0.479 | |
<70 | 157.5 (67.1) | |
≧70 | 143.5 (65.6) | |
Sex | 0.384 | |
Male | 145.1 (55.6) | |
Female | 163.8 (80.6) | |
Metastatic disease | 0.653 | |
Yes | 162.5 (41.2) | |
No | 151.5 (68.3) | |
Locally advanced disease | 0.071 | |
Yes | 173.8 (79.6) | |
No | 136.5 (50.0) | |
Distance from anal verge | 0.011* | |
≦5 cm | 157.6 (68.6) | |
>5 cm | 115.0 (25.7) | |
Complications during defuntioning period | 0.406 | |
Yes | 141.8 (67.1) | |
No | 158.5 (66.0) | |
Renal insufficiency during defunctioning period | 0.003* | |
Yes | 113.8 (36.3) | |
No | 163.5 (69.0) | |
Electrolyte imbalance during defunctioning period | 0.562 | |
Yes | 163.6 (73.4) | |
No | 149.1 (64.7) | |
Ileus during defunctioning period | <0.001* | |
Yes | 187.5 (3.5) | |
No | 150.9 (67.2) | |
Readmission during defunctioning period | 0.032* | |
Yes | 122.5 (42.1) | |
No | 161.0 (69.8) |